找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Ovarian Cancer; David S. Alberts,Earl A. Surwit Book 1985 Martinus Nijhoff Publishers, Boston 1985 Staging.cancer treatment.carcinoma.cell

[复制链接]
查看: 46787|回复: 44
发表于 2025-3-21 16:28:31 | 显示全部楼层 |阅读模式
书目名称Ovarian Cancer
编辑David S. Alberts,Earl A. Surwit
视频video
丛书名称Cancer Treatment and Research
图书封面Titlebook: Ovarian Cancer;  David S. Alberts,Earl A. Surwit Book 1985 Martinus Nijhoff Publishers, Boston 1985 Staging.cancer treatment.carcinoma.cell
描述Where do you begin to look for a recent, authoritative article on the diag­ nosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre­ quently publish good in-depth reviews of cancer topics, and published sym­ posium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by di­ viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by
出版日期Book 1985
关键词Staging; cancer treatment; carcinoma; cell; ovarian cancer; radiotherapy; surgery; tumor
版次1
doihttps://doi.org/10.1007/978-1-4613-2561-1
isbn_softcover978-1-4612-9609-6
isbn_ebook978-1-4613-2561-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightMartinus Nijhoff Publishers, Boston 1985
The information of publication is updating

书目名称Ovarian Cancer影响因子(影响力)




书目名称Ovarian Cancer影响因子(影响力)学科排名




书目名称Ovarian Cancer网络公开度




书目名称Ovarian Cancer网络公开度学科排名




书目名称Ovarian Cancer被引频次




书目名称Ovarian Cancer被引频次学科排名




书目名称Ovarian Cancer年度引用




书目名称Ovarian Cancer年度引用学科排名




书目名称Ovarian Cancer读者反馈




书目名称Ovarian Cancer读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

1票 100.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:12:47 | 显示全部楼层
发表于 2025-3-22 01:55:52 | 显示全部楼层
The human tumor clonogenic assay used to study ovarian cancers,47 showed that the addition of cisplatin to cyclophosphamide and doxorubicin improved response rates from 46% to 71% with the median duration of survival increasing from 9.5 months to 15.0 months [3]. The fact, however, becomes apparent that a. survival duration of 15 months is not a cure, and the g
发表于 2025-3-22 04:53:01 | 显示全部楼层
发表于 2025-3-22 10:52:48 | 显示全部楼层
发表于 2025-3-22 13:02:33 | 显示全部楼层
0927-3042 fashion. First, by di­ viding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by978-1-4612-9609-6978-1-4613-2561-1Series ISSN 0927-3042 Series E-ISSN 2509-8497
发表于 2025-3-22 18:02:57 | 显示全部楼层
Book 1985extbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals fre­ quently publish good in-depth reviews of cancer topics, and published sym­
发表于 2025-3-22 22:33:25 | 显示全部楼层
发表于 2025-3-23 03:54:51 | 显示全部楼层
发表于 2025-3-23 09:15:47 | 显示全部楼层
Multiagent chemotherapy in advanced ovarian carcinoma,e taken place. In fact, dealing with this tumor remains a frustrating experience to all cancer specialists. Advanced ovarian carcinoma (FIGO Stages III and IV) remains the most common gynecologic cancer killer with 18,200 estimated new cases and 11,500 estimated deaths in 1983 (6% of all female cancer deaths) [1].
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-2 15:04
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表